Cadmium effects on brain acetylcholinesterase activity and antioxidant status of adult rats: Modulation by zinc, calcium and L-cysteine co-administration

Basic and Clinical Pharmacology and Toxicology

Volumn 97, Issue 5, 2005, Pages 320-324

  Carageorgiou, Haris ^a   Tzotzes, Vassilios ^a   Sideris, Antonios ^a   Zarros, Apostolos ^a   Tsakiris, Stylianos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ANTIOXIDANT; CADMIUM; CALCIUM; CYSTEINE; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME MODIFICATION; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; VOCALIZATION;

ACETYLCHOLINESTERASE; ANIMALS; ANTIOXIDANTS; BRAIN; CADMIUM; CALCIUM; CYSTEINE; MALE; RATS; RATS, WISTAR; VOCALIZATION, ANIMAL; ZINC;

ANIMALIA;

EID: 27744437463     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto_174.x     Document Type: Article

References (38)

1. Andersson, H., K. Petersson-Grawe, E. Lindquist, J. Luthman, A. Oskarsson & L. Olson: Low-level cadmium exposure of lactating rats causes alterations in brain serotonin levels in the offsprings. Neurotoxicol. Teratol. 1997, 19, 105-115.
2. Brocardo, P. S., P. Pandolfo, R. N. Takahashi, A. L. Rodrighes & A. L. Dafre: Antioxidant defences and lipid peroxidation in the cerebral cortex and hippocampus following acute exposure to malathion and/or zinc chloride. Toxicology 2005, 207, 283-291.
3. Carageorgiou, H., St. Boviatsis, M. Carageorgiou-Kassaveti, C. Pantos, I. Messari & Z. Papadopoulou-Daifoti: Proceedings of the "2nd International symposium on trace elements in human: New perspectives". In: Dopamine, serotonin and their metabolite levels in certain rat brain areas after acute and chronic administration of cadmium. Eds.: S. Ermidou-Pollet, S. Pollet, Athens, Greece 7-9/1999 2000, pp. 723-730.
4. +)-ATPase activities, antioxidant status and learning performance of aged rats. Pharmacol. Res. 2003, 48, 245-251.
5. Carageorgiou, H., C. Liapi, I. Messari, C. Tyligada, G. Papadopoulos & N. Sitaras: Enviromental pharmacology. University of Athens 2004a, pp. 195-200 (in greek).
6. 2+-ATPase activities: protection by L-cysteine. Basic & Clinical Pharmacology & Toxicology 2004b, 94, 112-118.
7. Choi, D. W. & J. Y. Koh: Zinc and brain injury. Annu. Rev. Neurosci. 1998, 21, 347-375.
8. Committee on Care and Use of Laboratory Animals: Guide for the care and use of laboratory animals. Washington D.C.: Institute of Laboratory Animal Resources, National Research Council, 1985, pp. 83.
9. El-Demerdash, F. M., M. I. Yousef, F. S. Kedwany & H. H. Baghdadi: Cadmium-induced changes in lipid peroxidation, blood hepatology, biochemical parameters and semen quality of male rats: protective role of vitamin E and β-carotene. Food Chem. Toxicol. 2004, 42, 1563-1571.
10. Ellman, G. L., D. Courtney, D. Andres & R. M. Featherstone: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7, 88-95.
11. El-Missiry, M. A. & F. Shalaby: Role of beta-carotene in ameliorating the cadmium-induced oxidative stress in rat brain and testis. J. Biochem. Mol. Toxicol. 2000, 14, 238-243.
12. Emmett, S. R. & S. A. Greenfield: A peptide derived from the C-terminal region of acetylcholinesterase modulates extracellular concentrations of acetylcholinesterase in the rat substantia nigra. Neurosci. Lett. 2004, 358, 210-214.
13. Farinati, F., R. Cardin, R. D'inca, R. Naccarato & G. C. Sturniolo: Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease. J. Lab. Clin. Med. 2003, 141, 372-377.
14. Galaris, D. & A. Evangelou: The role of oxidative stress in mechanisms of metal-induced carcinogenesis. Crit. Rev. Oncol. Hematol. 2002, 42, 93-103.
15. th Edition. McGraw-Hill, 2001.
16. Kadoya, C., E. F. Domino, G. Y. Yang, J. D. Stern & A. L. Betz: Preischemic but not postischemic zinc protoporphyrin treatment reduces infarct size and edema accumulation after temporary focal cerebral ischemia in rats. Stroke 1995, 26, 1035-1038.
17. Klegeris, A., L. G. Korkina & S. A. Greenfield: A possible interaction between acetylcholinesterase and dopamine molecules during autoxidation of the amine. Free Radic. Biol. Med. 1995, 18, 223-230.
18. 2+ tntry in both cultured and in situ mouse astrocytes. Eur. J. Neurosci. 2005, 21, 1626-1634.
19. Lowry, O. H., N. J. Rosebrough, A. L. Farr & R. J. Randall: Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
20. Matsushita, K., K. Kitagawa, T. Matsuyama, T. Ohtsuki, A. Taguchi, K. Mandai, T. Mabuchi, Y. Yagita, T. Yanagihara & M. Matsumuto: Effect of systemic zinc administration on delayed neuronal death in the gerbil hippocampus. Brain Res. 1996, 743, 362-365.
21. Minami, A., A. Takeda, D. Nishibaba, S. Takefuta & N. Oka: Cadmium toxicity in synaptic neurotransmission in the brain. Brain Res. 2001, 894, 336-339.
22. Nolte, C., A. Gore, I. Sekler, W. Kresse, M. Hershfinkel, A. Hoffmann, H. Kettenmann & A. Moran: ZnT-1 expression in astroglial cells protects against zinc toxicity and slows the accumulation of intracellular zinc. Glia 2004, 48, 145-155.
23. Okuda, T., T. Haga, Y. Kanai, H. Endou, T. Ishihara & I. Katsura: Identification and characterization of the high-affinity choline transporter. Nat. Neurosci. 2000, 3, 120-125.
24. Oteiza, P. I., G. G. Mackenzie & S. V. Verstraeten: Metals in neurodegeneration: involvement of oxidants and oxidant-sensitive transcription factors. Mol. Aspects Med. 2004, 25, 103-115.
25. Patrick, L.: Toxic metals and antioxidants: Part II. The role of anti-oxidants in arsenic and cadmium toxicity. Altern. Med. Rev. 2003, 8, 106-128.
26. Powell, S. R.: The antioxidant properties of zinc. J. Nutr. 2000, 130, 1447S-1454S.
27. Provias, J. P., C. A. Acherley, C. Smith & L. E. Becker: Cadmium encephalopathy: a report with elemental analysis and pathological findings. Acta Neuropathol. 1994, 88, 538-586.
28. Soreq, H. & S. Seidman: Acetylcholinesterase-new roles for an old actor. Nat. Rev. Neurosci. 2001, 2, 294-302.
29. Stehbens, W. E.: Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc. Exp. Mol. Pathol. 2003, 75, 265-276.
30. Sudhof, T. C.: The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature 1995, 375, 645-653.
31. Sutoo, D., K. Akiyama & S. Imamiya: A mechanism of cadmium poisoning: the cross effect of calcium and cadmium in the calmodulin-dependent system. Arch. Toxicol. 1990, 64, 161-164.
32. Tandon, S. K., S. Singh, S. Prasad, K. Khandekar, V. K. Dwivedi, M. Chatterjee & N. Mathur: Reversal of cadmium induced oxidative stress by chelating agent, antioxidant or their combination in rat. Toxicol. Lett. 2003, 145, 211-217.
33. +-ATPase inhibition induced by free radicals. Z. Naturforsch. 2000a, 55, 271-277.
34. Tsakiris, S., C. Antoniades & K. Marinou: Pseudocholinesterase activity distribution in rat brain: detection in aged hypothalamus and frontal cortex. Med. Sci. Res. 2000b, 28, 117-118.
35. Tsakiris, S., P. Angelogianni, K. H. Schulpis & J. C. Stavridis: Protective effect of L-phenylalanine on rat brain acetylcholinesterase inhibition induced by free radicals. Clin. Biochem. 2000c, 33, 103-106.
36. Webb, C. P., S. Nedergaard, K. Giles & S. A. Greenfield: Involvement of the NMDA receptor in a non-cholinergic action of acetylcholinesterase in guinea-pig substantia nigra pars compacta neurons. Eur. J. Neurosci. 1996, 8, 837-841.
37. Whyte, K. A. & S. A. Greenfield: Effects of acetylcholinesterase and butyrylcholinesterase on cell survival, neurite outgrowth, and voltage-dependent calcium currents of embryonic ventral mesencephalic neurones. Exp. Neurol. 2003, 184, 496-509.
38. Yousef, M. I., H. A. El-Hendy, F. M. El-Demerdash & E. I. Elagamy: Dietary zinc deficiency induced-changes in the activity of enzymes and the levels of free radicals, lipids and protein electrophoretic behavior in growing rats. Toxicology 2002, 175, 223-234.